An Observational study to assess the Prevalence of Heart Failure in Type 2 Diabetes Patients - HF-Registry

Study identifier:D1843R00300

ClinicalTrials.gov identifier:NCT04072523

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An Observational, Cross sectional Study to assess the Prevalence of Heart Failure in Type 2 Diabetes Patients in India

Medical condition

Type 2 Diabetes

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

621

Study type

Observational

Age

N/A

Date

Study Start Date: 03 Dec 2019
Primary Completion Date: 01 Mar 2021
Study Completion Date: 01 Mar 2021

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Feb 2022 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria